Thijs JC - Search Results

1

Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing.

van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, van Zwet AA. van der Wouden EJ, et al. Among authors: thijs jc. Antimicrob Agents Chemother. 1999 Jun;43(6):1484-6. doi: 10.1128/AAC.43.6.1484. Antimicrob Agents Chemother. 1999. PMID: 10348776 Free PMC article.

2

Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.

Gerrits MM, van der Wouden EJ, Bax DA, van Zwet AA, van Vliet AH, de Jong A, Kusters JG, Thijs JC, Kuipers EJ. Gerrits MM, et al. Among authors: thijs jc. J Med Microbiol. 2004 Nov;53(Pt 11):1123-1128. doi: 10.1099/jmm.0.45701-0. J Med Microbiol. 2004. PMID: 15496391 Free article.

3

Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period.

Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Arents NL, et al. Among authors: thijs jc. Eur J Gastroenterol Hepatol. 2004 Aug;16(8):779-83. doi: 10.1097/01.meg.0000108367.19243.73. Eur J Gastroenterol Hepatol. 2004. PMID: 15256980

4

Treatment of Helicobacter pylori infections.

Thijs JC, Kuipers EJ, van Zwet AA, Pena AS, de Graaff J. Thijs JC, et al. QJM. 1995 Jun;88(6):369-89. QJM. 1995. PMID: 7648229 Review.

5

Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

van Zwet AA, Thijs JC, de Graaf B. van Zwet AA, et al. Among authors: thijs jc. Antimicrob Agents Chemother. 1995 Jan;39(1):250-2. doi: 10.1128/AAC.39.1.250. Antimicrob Agents Chemother. 1995. PMID: 7695317 Free PMC article.

6

Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.

Thijs JC, Van Zwet AA, Moolenaar W, Oom JA, De Korte H, Runhaar EA. Thijs JC, et al. Aliment Pharmacol Ther. 1994 Feb;8(1):131-4. doi: 10.1111/j.1365-2036.1994.tb00170.x. Aliment Pharmacol Ther. 1994. PMID: 8186339 Clinical Trial.

7

In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.

van Zwet AA, Thijs JC, Schievink-de Vries W, Schiphuis J, Snijder JA. van Zwet AA, et al. Among authors: thijs jc. Antimicrob Agents Chemother. 1994 Feb;38(2):360-2. doi: 10.1128/AAC.38.2.360. Antimicrob Agents Chemother. 1994. PMID: 8192465 Free PMC article.

8

Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

Thijs JC, Van Zwet AA, Oey HB. Thijs JC, et al. Scand J Gastroenterol. 1993 Nov;28(11):934-8. doi: 10.3109/00365529309098287. Scand J Gastroenterol. 1993. PMID: 8284626 Clinical Trial.

9

Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.

Thijs JC, van Zwet AA, Moolenaar W, Wolfhagen MJ, ten Bokkel Huinink J. Thijs JC, et al. Am J Gastroenterol. 1996 Jan;91(1):93-7. Am J Gastroenterol. 1996. PMID: 8561152 Clinical Trial.

10

Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard.

Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, Luijt DS, Meyer BC, Kleibeuker JH. Thijs JC, et al. Among authors: thijs wj. Am J Gastroenterol. 1996 Oct;91(10):2125-9. Am J Gastroenterol. 1996. PMID: 8855734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters